Variables | UHS | UFO | SCOPE | Total all studies |
---|---|---|---|---|
Total N | 202 | 128 | 130 | 460 |
Gender N(%)¶ |  |  |  |  |
Male | 145 (72.5%) | 88 (68.8%) | 85 (65.4%) | 318 (69.4%) |
Female | 55 (27.5%) | 40 (31.2%) | 45 (34.6%) | 140 (30.6%) |
Age (in years)# | Â | Â | Â | Â |
Median | 47.0 | 22.3 | 45.0 | 43.0 |
IQR | 42.3-50.0 | 19.9-25.0 | 40.8-49.0 | 28.0 - 48.0 |
Years of recruitment | 1987-1998 | 2000-2007 | 2000-2007 | 1987-2007 |
HCV Genotypes* ¶ |  |  | 95 (77.9%) | 326 (72.4%) |
Type 1 | 161 (80.5%) | 70 (54.7%) | 10 (8.2%) | 50 (11.1%) |
Type 2 | 22 (11.0%) | 18 (14.1%) | 15 (12.3%) | 69 (15.3%) |
Type 3 | 15 (7.5%) | 39 (30.5%) | 2 (1.6%) | 5 (11.1%) |
Type 4 | 2 (1.0%) | 1 (0.8%) | 122 (100%) | #*** |
 | #* |  | #** |  |
HCV Genotypes*¶ |  |  |  |  |
1 | 15 (7.4%) | 32 (25.0%) | 62 (47.7%) | 110 (23.9%) |
1a | 76 (37.6%) | 26 (20.3%) | 3 (2.3%) | 105 (22.8%) |
1a/1b | 5 (2.5%) | 1 (0.8%) | 4 (3.1%) | 10 (2.2%) |
1b | 65 (32.2%) | 11 (8.6%) | 26 (20.0%) | 101 (22.0%) |
1/2 | 1 (0.5%) | 0 (0.0%) | 0 (0.0%) | 1 (0.2%) |
2 | 1 (5.0%) | 5 (3.9%) | 0 (0%) | 5 (1.1%) |
2a | 0 (0.0%) | 1 (0.8%) | 0 (0.0%) | 1 (0.2%) |
2a/2c | 4 (2.0%) | 6 (4.7%) | 2 (1.5%) | 12 (2.6%) |
2b | 17 (8.4%) | 6 (4.7%) | 3 (2.3%) | 26 (5.7%) |
2b/3a | 1 (0.5%) | 0 (0.0%) | 0 (0.0%) | 1 (0.2%) |
3a | 15 (7.4%) | 39 (30.5%) | 15 (11.5%) | 69 (15.0%) |
4 | 1 (0.5%) | 0 (0.0%) | 1 (0.8%) | 4(0.4%) |
4c/4d | 1 (0.5%) | 1 (0.8%) | 1 (0.8%) | 3(0.7%) |
Undetermined | 0 (0.0%) | 0 (0.0%) | 8 (6.2%) | 8 (1.7%)** |
Ethnicity¶ |  |  |  |  |
Caucasian | 55 (27.5%) | 97 (75.8%) | 54 (41.5%) | 205 (44.8%) |
African Amer. | 124 (62.0%) | 2 (1.6%) | 54 (41.5%) | 180 (39.3%) |
Latino | 10 (5.0%) | 7 (5.5%) | 9 (6.9%) | 26 (5.7%) |
Asian | 1 (0.5%) | 1 (0.8%) | 3 (2.3%) | 5 (1.1%) |
Other | 10 (5.0%) | 21 (16.4%) | 10 (7.7%) | 42 (9.2%)** |
Education (1)¶ |  |  |  |  |
< High School | 56 (28.0%) | 67 (52.8%) | 34 (26.2%) | 157 (34.4%) |
>= High school | 144 (72.0%) | 60 (47.2%) | 96 (73.8%) | 300 (65.6%)** |